Published in Fam Cancer on June 13, 2007
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer (2007) 1.82
Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol (2010) 1.62
Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer. World J Gastroenterol (2014) 1.16
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J (2011) 1.13
Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations. J Thorac Oncol (2014) 1.04
Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. ScientificWorldJournal (2014) 1.03
The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes. Dtsch Arztebl Int (2010) 0.99
Genetics of the hamartomatous polyposis syndromes: a molecular review. Int J Colorectal Dis (2009) 0.95
Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review). Oncol Lett (2013) 0.94
Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression. Oxid Med Cell Longev (2015) 0.91
Genetic predisposition to colorectal cancer: where we stand and future perspectives. World J Gastroenterol (2014) 0.90
Primary acantholytic squamous cell carcinoma of the cecum: a case report. Diagn Pathol (2011) 0.89
The impact of family history on the outcome of patients with colorectal cancer in a veterans' hospital. Int J Colorectal Dis (2009) 0.89
Role for epithelial dysregulation in early-onset colitis-associated colon cancer in Gi2-alpha-/- mice. Inflamm Bowel Dis (2008) 0.82
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine. Fam Cancer (2016) 0.81
Mismatch repair protein expression in colorectal cancer. J Gastrointest Oncol (2013) 0.79
Tgf-Beta superfamily receptors-targets for antiangiogenic therapy? J Oncol (2010) 0.77
Barrett's esophagus in the patients with familial adenomatous polyposis. Fam Cancer (2014) 0.77
Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. J Pediatr Surg (2016) 0.76
Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice. Cancer Sci (2015) 0.75
BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status. J Korean Med Sci (2017) 0.75
Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer. Int J Environ Res Public Health (2016) 0.75
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41
Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med (1949) 8.32
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell (1996) 7.86
Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology (1997) 7.58
Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet (2002) 7.00
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet (2001) 6.36
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med (2003) 4.88
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res (2006) 4.26
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA (2005) 3.99
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res (2006) 3.81
Familial adenomatous polyposis. Am J Gastroenterol (2006) 3.77
Serrated adenomatous polyposis in humans. Gastroenterology (1996) 3.30
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet (1986) 2.78
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology (2001) 2.68
ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc (2006) 2.63
Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA (2005) 2.59
Juvenile polyposis--a precancerous condition. Histopathology (1988) 2.47
The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol (2005) 2.42
Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat (2006) 2.39
Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol (2001) 2.29
Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol (2005) 2.22
Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc (1991) 2.17
Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet (2005) 2.17
Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. J Pathol (1999) 2.13
Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst (1990) 2.11
Peutz-Jeghers syndrome. J Med Genet (1997) 2.01
Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology (1997) 1.96
Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. Gastroenterology (2001) 1.88
Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child (1991) 1.81
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol (2002) 1.74
Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term. World J Gastroenterol (2006) 1.70
Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet (1992) 1.69
Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res (2004) 1.68
Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology (2006) 1.66
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet (2006) 1.59
Peutz-Jeghers syndrome with ovarian sex cord tumor with annular tubules and cervical adenoma malignum. Gynecol Oncol (1991) 1.56
Juvenile polyposis coli. J Med Genet (1966) 1.56
Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol (1983) 1.48
MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer (2006) 1.46
Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet (1999) 1.46
The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev (2006) 1.41
Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol (1995) 1.41
Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res (2003) 1.40
Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab (2000) 1.39
Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology (2006) 1.34
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol (2002) 1.34
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut (2000) 1.34
Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet (1998) 1.26
Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases. Hum Pathol (1999) 1.26
Peutz-Jeghers syndrome. Radiographics (1992) 1.23
The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective "back-to-back" endoscopic study. Am J Gastroenterol (2005) 1.23
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet (2003) 1.21
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13
Abnormal vascular network complexity: a new phenotypic marker in hereditary non-polyposis colorectal cancer syndrome. Gut (2003) 1.11
Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. Am J Hum Genet (1996) 1.09
Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res (2005) 1.07
Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol (2005) 1.05
Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol (2004) 1.04
Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function. J Med Genet (2006) 1.03
Desmoid tumors -- a characterization of patients seen at Mayo Clinic 1976-1999. Fam Cancer (2006) 0.96
Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg (2004) 0.96
Inherited predisposition to cancer: a historical overview. Am J Med Genet C Semin Med Genet (2004) 0.92
Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer (2006) 0.92
Testing for defective DNA mismatch repair in colorectal carcinoma: a practical guide. Arch Pathol Lab Med (2005) 0.89
Hereditary intestinal cancer. Semin Cancer Biol (2000) 0.88
Cronkhite-Canada syndrome: radiologic features. Gastrointest Radiol (1989) 0.87
Juvenile polyposis: a case with early presentation and death attributable to adenocarcinoma of the pancreas. Am J Med Genet (1989) 0.86
Diagnosis and management of gastrointestinal polyps: pediatric considerations. Gastroenterol Nurs (2006) 0.85
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis. Gastroenterology (2006) 0.84
Enteritis cystica profunda in Peutz-Jeghers syndrome. Report of a case and review of the literature. Dis Colon Rectum (1987) 0.83
Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer. Dis Markers (2004) 0.83
High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not? Eur J Gastroenterol Hepatol (2003) 0.82
Decoding hereditary colorectal cancer. N Engl J Med (2006) 0.81
Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum (1993) 0.80
A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol (2003) 0.76
Bilateral large-cell calcifying Sertoli cell tumor of the testes with Peutz-Jeghers syndrome: a case report. Pediatr Dermatol (1994) 0.75
Genodermatoses with malignant potential. Am Fam Physician (1992) 0.75
Significance of the smooth muscle cell component in Peutz-Jeghers and juvenile polyps. Hum Pathol (1991) 0.75
Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer. J Thorac Oncol (2014) 1.55
Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen. Mod Pathol (2005) 1.40
Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol (2004) 1.37
Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer. J Cell Biochem (2006) 1.09
Simultaneous EBV-positive lymphoepithelioma-like carcinoma and EBV-negative intestinal-type adenocarcinoma in a patient with Helicobacter pylori-associated chronic gastritis. Am J Clin Pathol (2004) 1.04
Interaction among heme oxygenase, nuclear factor-kappaB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension (2008) 0.99
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. Clin Cancer Res (2003) 0.98
Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol (2008) 0.96
Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol (2004) 0.91
Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms. Hum Pathol (2009) 0.87
The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma. J Pathol (2004) 0.85
RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression. J Hematol Oncol (2009) 0.84
Utility of a CEA, CD15, calretinin, and CK5/6 panel for distinguishing between mesotheliomas and pulmonary adenocarcinomas in clinical practice. Am J Surg Pathol (2012) 0.83
Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol (2002) 0.83
Nordic immunohistochemical quality control. Croat Med J (2005) 0.81
Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53. Int J Surg Pathol (2005) 0.80
Volume-related sequence of tumor distribution pattern in prostate carcinoma: importance of posterior midline crossover in predicting tumor volume, extracapsular extension, and seminal vesicle invasion. Croat Med J (2005) 0.79
Easy method of assessing volume of prostate adenocarcinoma from estimated tumor area: using prostate tissue density to bridge gap between percentage involvement and tumor volume. Croat Med J (2005) 0.79
Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients. Am J Dermatopathol (2005) 0.78
Canadian external quality assurance program for breast cancer biomarkers. Appl Immunohistochem Mol Morphol (2010) 0.77
A pathologist's survey on the reporting of sessile serrated adenomas/polyps. J Clin Pathol (2014) 0.76
Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study. Appl Immunohistochem Mol Morphol (2015) 0.75
Renal smooth muscle hamartoma. Pathol Res Pract (2010) 0.75
CD34/QBEND10 immunostaining in the bone marrow trephine biopsy: a study of CD34-positive mononuclear cells and megakaryocytes. Arch Pathol Lab Med (2002) 0.75